Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial
- Conditions
- Cocaine-related Disorders
- Interventions
- Behavioral: Cognitive behavioral therapy (CBT)
- Registration Number
- NCT00877435
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Brief Summary
The purpose of this study is to determine whether prize-based contingency management (prizeCM) combined with cognitive behavioral therapy (CBT) is more effective in the treatment of of cocaine-dependent patients compared to CBT only. Patients were randomized to prizeCM + CBT (experimental group) or to CBT (control group) an treated over 24 weeks. It is the first trial of this type in Europe.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- cocaine dependence, aged 18 or older, other dependences
- severe somatic, brain, or psychiatric disease, attention deficit disorders with medication methylphenidate
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Cognitive behavioral therapy (CBT) Cognitive behavioral therapy (CBT) 1 Cognitive behavioral therapy (CBT) Cognitive behavioral therapy (CBT) + prize-based contingency management (prizeCM)
- Primary Outcome Measures
Name Time Method retention in treatment, cocaine abstinence 24 weeks cocaine abstinence: at least 3 consecutive weeks of cocaine abstinence, the maximum number of weeks of continous abstinence and proportions of cocaine-free urine samples during the entire 24-week and at 6-month follow-up.
- Secondary Outcome Measures
Name Time Method patients' satisfaction with the therapy, clinical measures 24 weeks patients' satisfaction with prize-based contingency management and with CBT
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
Fondation Phenix
🇨🇭Geneva, Switzerland
Universitäre Psychiatrischen Kliniken
🇨🇭Basel, Switzerland